Altered profile of chemokines in fibromyalgia patients

Annals of Clinical Biochemistry

Volumn 51, Issue 5, 2014, Pages 576-581

  García, Juan J ^a   Cidoncha, Antonio ^b   Bote, María E ^a   Hinchado, María D ^a   Ortega, Eduardo ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b HOSPITAL DON BENITO VILLANUEVA   (Spain)

Author keywords

biomarkers; chemokines; diagnosis; Fibromyalgia

Indexed keywords

CC CHEMOKINE 4; CHEMOKINE; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; EOTAXIN; MACROPHAGE DERIVED CHEMOKINE; PULMONARY AND ACTIVATION REGULATED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG; BETA CHEMOKINE; BIOLOGICAL MARKER; CCL11 PROTEIN, HUMAN; CCL16 PROTEIN, HUMAN; CCL17 PROTEIN, HUMAN; CCL18 PROTEIN, HUMAN; CCL22 PROTEIN, HUMAN; CXCL11 PROTEIN, HUMAN; CXCL9 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROMYALGIA; HUMAN; PRIORITY JOURNAL; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL11; CHEMOKINE CCL17; CHEMOKINE CCL22; CHEMOKINE CXCL11; CHEMOKINE CXCL9; CHEMOKINES; CHEMOKINES, CC; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED;

EID: 84906330083     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563213506413     Document Type: Article

References (33)

1. Ransohoff RM.Chemokines and chemokine receptors: standing at the cross roads of immunobiology and neurobiology.Immunity. 2009;31:711-721.
2. Blanchet X,Langer M,Weber C, et al.Touch of chemokines.Front Immunol. 2012;3:175-175.
3. Nomiyama H,Osada N,Yoshie O.The evolution of mammalian chemokine genes.Cytokine Growth Factor Rev. 2010;21:253-262.
4. Mantovani A,Bonecchi R,Locati M.Tuning inflammation and immunity by chemokine sequestration: decoys and more.Nat Rev Immunol. 2006;6:907-918.
5. Saeki H,Tamaki K.Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases.J Dermatol Sci. 2006;43:75-84.
6. Abbadie C.Chemokines, chemokine receptors and pain.Trends Immunol. 2005;26:529-534.
7. White FA,Jung H,Miller RJ.Chemokines and the pathophysiology of neuropathic pain.Proc Natl Acad Sci U S A. 2007;104:20151-20158.
8. Wolfe F,Smythe HA,Yunus MB, et al.The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee.Arthritis Rheum. 1990;33:160-172.
9. Torpy DJ,Papanicolaou DA,Lotsikas AJ, et al.Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.Arthritis Rheum. 2000;43:872-880.
10. Mease P,Arnold LM,Bennett R, et al.Fibromyalgia syndrome.J Rheumatol. 2007;34:1415-1425.
11. Ablin J,Neumann L,Buskila D.Pathogenesis of fibromyalgia - a review.Joint Bone Spine. 2008;75:273-279.
12. Van West D,Maes M.Neuroendocrine and immune aspects of fibromyalgia.BioDrugs. 2001;15:521-531.
13. Omoigui S.The biochemical origin of pain - proposing a new law of pain: the origin of all pain is inflammation and the inflammatory response. Part 1 of 3 - a unifying law of pain.Med Hypotheses. 2007;69:70-82.
14. Omoigui S.The biochemical origin of pain: the origin of all pain is inflammation and the inflammatory response. Part 2 of 3 - inflammatory profile of pain syndromes.Med Hypotheses. 2007;69:1169-1178.
15. Wallace DJ,Linker-Israeli M,Hallegua D, et al.Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study.Rheumatology (Oxford). 2001;40:743-749.
16. Gür A,Karakoç M,Nas K, et al.Cytokines and depression in cases with fibromyalgia.J Rheumatol. 2002;29:358-361.
17. Wang H,Moser M,Schiltenwolf M, et al.Circulating cytokine levels compared to pain in patients with fibromyalgia - a prospective longitudinal study over 6 months.J Rheumatol. 2008;35:1366-1370.
18. Ortega E,García JJ,Bote ME, et al.Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances.Exerc Immunol Rev. 2009;15:42-65.
19. Bote ME,García JJ,Hinchado MD, et al.Inflammatory/stress feedback dysregulation in women with fibromyalgia.Neuroimmunomodulation. 2012;19:343-351.
20. Ortega E,Bote ME,Giraldo E, et al.Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patients.Scand J Med Sci Sports. 2012;22:104-112.
21. Zhang Z,Cherryholmes G,Mao A, et al.High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia.Exp Biol Med (Maywood). 2008;233:1171-1180.
22. Müller W,Schneider EM,Stratz T.The classification of fibromyalgia syndrome.Rheumatol Int. 2007;27:1005-1010.
23. Baggiolini M,Dewald B,Moser B.Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines.Adv Immunol. 1994;55:97-179.
24. Cunha FQ,Lorenzetti BB,Poole S, et al.Interleukin-8 as a mediator of sympathetic pain.Br J Pharmacol. 1991;104:765-767.
25. Saito N,Chihara J.Chemokine (RANTES, eotaxin, etc.).Nihon Rinsho. 2001;59:1900-1905.
26. Gear AR,Camerini D.Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense.Microcirculation. 2003;10:335-350.
27. Gasperini S,Marchi M,Calzetti F, et al.Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.J Immunol. 1999;162:4928-4937.
28. Müller M,Carter S,Hofer MJ, et al.Review: the chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum.Neuropathol Appl Neurobiol. 2010;36:368-387.
29. Van Coillie E,Van Damme J,Opdenakker G.The MCP/eotaxin subfamily of CC chemokines.Cytokine Growth Factor Rev. 1999;10:61-86.
30. Auer J,Bläss M,Schulze-Koops H, et al.Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis.Arthritis Res Ther. 2007;9:R94-R94.
31. Chang Y,De Nadai P,Azzaoui I, et al.The chemokine CCL18 generates adaptive regulatory T cells from memory CD4+ T cells of healthy but not allergic subjects.FASEB J. 2010;24:5063-5072.
32. Hedrick JA,Helms A,Vicari A, et al.Characterization of a novel CC chemokine, HCC-4, whose expression is increased by interleukin-10.Blood. 1998;91:4242-4247.
33. Kodelja V,Müller C,Politz O, et al.Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern.J Immunol. 1998;160:1411-1418.